OrthoPediatrics Corp.
NASDAQOrthoPediatrics Corp. delivered a strong enough quarter to move the Street, with the stock up 5.2% on the week to $20.88 and two analyst upgrades in the analysts' notebooks within 24 hours of results — the sharpest burst of analyst activity the name has seen in months. The Street reaction was swift and constructive. Needham raised its target from $30 to $35 — maintaining a Buy…
Snapshot as of 16 Aug 2026
OrthoPediatrics Corp. delivered a strong enough quarter to move the Street, with the stock up 5.2% on the week to $20.88 and two analyst upgrades in the analysts' notebooks within 24 hours of results — the sharpest…
OrthoPediatrics Corp. has spent the past month quietly rerating, with the stock up nearly 20% to $19.95 and short sellers trimming positions — yet the analyst community has barely moved since earnings, leaving a gap…
OrthoPediatrics Corp. reports Q1 2026 results on May 4 with the stock trading near multi-year lows — down 17.6% year-to-date — and a lending market that signals bears are pulling back, not pressing in. Short sellers…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for KIDS — free to start on ORTEX.
Sign up for free →Open KIDS on ORTEX